Predictions
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.42
22.01.23
22.01.23
-
22.01.24
22.01.24
12.21%
05.02.23
05.02.23
Could be very worthwhile Investment >20% year
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
21.01.23
21.01.23
-
24.05.24
24.05.24
-
26.01.23
26.01.23
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.80
10.12.22
10.12.22
-
10.12.23
10.12.23
-21.61%
24.12.22
24.12.22
Risky Investment
Canopy Growth Corp
Start price
Target price
Perf. (%)
€3.58
21.11.22
21.11.22
-
21.11.23
21.11.23
-85.09%
22.11.23
22.11.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Canopy Growth Corp
Start price
Target price
Perf. (%)
€3.63
19.11.22
19.11.22
€2.50
19.11.23
19.11.23
-46.91%
11.03.23
11.03.23
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.38
25.10.22
25.10.22
€3.50
25.10.23
25.10.23
-73.82%
05.09.23
05.09.23
Could be worthwhile Investment >10% per year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.44
17.10.22
17.10.22
-
17.10.23
17.10.23
-7.41%
22.12.22
22.12.22
Risky Investment
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.55
13.10.22
13.10.22
€2.30
13.10.23
13.10.23
42.55%
19.11.22
19.11.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€6.63
05.09.22
05.09.22
-
05.09.23
05.09.23
15.97%
06.09.23
06.09.23
Canopy Growth Corp
Start price
Target price
Perf. (%)
€4.29
26.08.22
26.08.22
€6.00
26.08.23
26.08.23
-41.69%
13.10.22
13.10.22
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€5.40
23.08.22
23.08.22
-
23.08.23
23.08.23
29.96%
09.09.22
09.09.22
Capable Management
Probably not worthwhile Investment
Revenue decline/stagnation expected
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
08.08.22
08.08.22
-
08.08.26
08.08.26
-
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.91
03.08.22
03.08.22
€3.30
03.08.23
03.08.23
-12.37%
13.10.22
13.10.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€4.11
28.07.22
28.07.22
-
28.07.23
28.07.23
35.16%
14.05.23
14.05.23
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€8.45
11.07.22
11.07.22
-
11.07.23
11.07.23
-39.77%
04.08.22
04.08.22
Capable Management
Probably not worthwhile Investment
Revenue decline/stagnation expected
Canopy Growth Corp
Start price
Target price
Perf. (%)
€3.59
27.06.22
27.06.22
-
27.06.23
27.06.23
-27.90%
09.07.22
09.07.22
Risky Investment